Dysregulation of eNOS and decreased endothelial NO bioavailability can be seen in chronic inflammatory diseases such as hypertension and may be critical in predisposing individuals to higher severity of COVID-19 [81]. This evidence concerns the gene NOS3 and COVID-19.